Cargando…
Soluble Urokinase Plasminogen Activator Receptor Level Is an Independent Predictor of the Presence and Severity of Coronary Artery Disease and of Future Adverse Events
INTRODUCTION: Soluble urokinase plasminogen activator receptor (suPAR) is an emerging inflammatory and immune biomarker. Whether suPAR level predicts the presence and the severity of coronary artery disease (CAD), and of incident death and myocardial infarction (MI) in subjects with suspected CAD, i...
Autores principales: | Eapen, Danny J., Manocha, Pankaj, Ghasemzedah, Nima, Patel, Riyaz S., Al Kassem, Hatem, Hammadah, Muhammad, Veledar, Emir, Le, Ngoc‐Anh, Pielak, Tomasz, Thorball, Christian W., Velegraki, Aristea, Kremastinos, Dimitrios T., Lerakis, Stamatios, Sperling, Laurence, Quyyumi, Arshed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323820/ https://www.ncbi.nlm.nih.gov/pubmed/25341887 http://dx.doi.org/10.1161/JAHA.114.001118 |
Ejemplares similares
-
Novel Biomarker of Oxidative Stress Is Associated With Risk of Death in Patients With Coronary Artery Disease
por: Patel, Riyaz S., et al.
Publicado: (2016) -
Soluble Urokinase Plasminogen Activator Receptor as a Marker for Use of Antidepressants
por: Haastrup, Eva, et al.
Publicado: (2014) -
Sex Differences in Circulating Soluble Urokinase‐Type Plasminogen Activator Receptor (suPAR) Levels and Adverse Outcomes in Coronary Artery Disease
por: Mehta, Anurag, et al.
Publicado: (2020) -
Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency
por: Höybye, Charlotte, et al.
Publicado: (2019) -
Soluble Urokinase‐Type Plasminogen Activator Receptor and High‐Sensitivity Troponin Levels Predict Outcomes in Nonobstructive Coronary Artery Disease
por: Al‐Badri, Ahmed, et al.
Publicado: (2020)